(COMBO) This combination of pictures created on December 11, 2020 shows (FILES) This file undated handout picture released by the University of Oxford on November 23, 2020 shows a vial of the University's COVID-19 candidate vaccine, known as AZD1222, co-invented by the University of Oxford and Vaccitech in partnership with pharmaceutical giant AstraZeneca. (FILES) In this file photo taken on December 04, 2020, production of Russia's Gam-COVID-Vac vaccine against Covid-19 registered under trade name Sputnik V, developed by the Gamaleya Research Institute of Epidemiology and Microbiology in coordination with the Russian Defence Ministry, at the facility of Russia's biotech company BIOCAD in Strelna outside Saint Petersburg. - Pharmaceutical giant AstraZeneca's Russian branch said on December 11, 2020 it would use part of Russia's homemade Sputnik V vaccine in further clinical trials. (Photos by John Cairns and Olga MALTSEVA / various sources / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO / UNIVERSITY OF OXFORD / John Cairns " - NO MARKETING - NO ADVERTISING CAMPAIGNS - RESTRICTED TO ILLUSTRATING STORIES RELATED TO THE PARTICULAR VACCINE, EVENTS AND FACTS MENTIONED IN THE CAPTION - DISTRIBUTED AS A SERVICE TO CLIENTS / (Photo by JOHN CAIRNS,OLGA MALTSEVA/AFP via Getty Images)
NOTICIAS LOCALES

SEGUNDA DOSIS DE PFIZER INDICADA COMO PASO DOS EN LA COMBINACION CON LA SPUTNIK V

10 de agosto de 2021
By Redaction

El equipo técnico responsable de la validación de normas en temas de vacunas en Honduras dictaminó de forma positiva la aplicación de la vacuna Sputnik V o Gam-COVID-Vac en el país y la combinación del segundo componente de Pfizer para cubrir el programa de vacunas en una población de más de 40 mil personas que esperan el componente ruso, como un plan B ante un posible incumplimiento del fondo ruso y así contribuir en la prevención de esta enfermedad letal que azota a Honduras desde marzo de 2020.